The postmenopausal hormone replacement therapy-related breast cancer risk is decreased in women carrying the CYP2C19*17 variant

Christina Justenhoven, Ofure Obazee, Stefan Winter, Fergus J. Couch, Janet E. Olson, Per Hall, Ulf Hannelius, Jingmei Li, Keith Humphreys, Gianluca Severi, Graham Giles, Melissa Southey, Laura Baglietto, Peter A. Fasching, Matthias W. Beckmann, Arif B. Ekici, Ute Hamann, Christian Baisch, Volker Harth, Sylvia RabsteinAnne Lotz, Beate Pesch, Thomas Brüning, Yon Dschun Ko, Hiltrud Brauch

Research output: Contribution to journal › Letter › peer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'The postmenopausal hormone replacement therapy-related breast cancer risk is decreased in women carrying the CYP2C19*17 variant'. Together they form a unique fingerprint.